107 related articles for article (PubMed ID: 11005787)
1. Do present damage and health perception in patients with systemic lupus erythematosus predict extent of future damage?: a prospective study.
Stoll T; Sutcliffe N; Klaghofer R; Isenberg DA
Ann Rheum Dis; 2000 Oct; 59(10):832-5. PubMed ID: 11005787
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the relationship between disease activity and damage in patients with systemic lupus erythematosus--a 5-yr prospective study.
Stoll T; Sutcliffe N; Mach J; Klaghofer R; Isenberg DA
Rheumatology (Oxford); 2004 Aug; 43(8):1039-44. PubMed ID: 15161983
[TBL] [Abstract][Full Text] [Related]
3. Association of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index with measures of disease activity and health status in patients with systemic lupus erythematosus.
Stoll T; Stucki G; Malik J; Pyke S; Isenberg DA
J Rheumatol; 1997 Feb; 24(2):309-13. PubMed ID: 9034988
[TBL] [Abstract][Full Text] [Related]
4. Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study.
Mok CC; Ho LY; Cheung MY; Yu KL; To CH
Scand J Rheumatol; 2009; 38(2):121-7. PubMed ID: 18991189
[TBL] [Abstract][Full Text] [Related]
5. Predictors of Organ Damage Progression and Effect on Health-related Quality of Life in Systemic Lupus Erythematosus.
Legge A; Doucette S; Hanly JG
J Rheumatol; 2016 Jun; 43(6):1050-6. PubMed ID: 27084911
[TBL] [Abstract][Full Text] [Related]
6. Charlson Comorbidity Index Is Related to Organ Damage in Systemic Lupus Erythematosus: Data from KORean lupus Network (KORNET) Registry.
Kim SK; Choe JY; Lee SS
J Rheumatol; 2017 Apr; 44(4):452-458. PubMed ID: 28298561
[TBL] [Abstract][Full Text] [Related]
7. High predictive value of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for survival in systemic lupus erythematosus.
Nived O; Jönsen A; Bengtsson AA; Bengtsson C; Sturfelt G
J Rheumatol; 2002 Jul; 29(7):1398-400. PubMed ID: 12136895
[TBL] [Abstract][Full Text] [Related]
8. The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: results from a monocentric cohort.
Conti F; Ceccarelli F; Perricone C; Leccese I; Massaro L; Pacucci VA; Truglia S; Miranda F; Spinelli FR; Alessandri C; Valesini G
Lupus; 2016 Jun; 25(7):719-26. PubMed ID: 26821965
[TBL] [Abstract][Full Text] [Related]
9. Further validation of the BILAG disease activity index in patients with systemic lupus erythematosus.
Stoll T; Stucki G; Malik J; Pyke S; Isenberg DA
Ann Rheum Dis; 1996 Oct; 55(10):756-60. PubMed ID: 8984942
[TBL] [Abstract][Full Text] [Related]
10. Multicenter study to assess presenteeism in systemic lupus erythematosus and its relationship with clinical and sociodemographic features.
Cosatti MA; Muñoz S; Alba P; Helling CA; Roverano S; Sarano J; Malm-Green S; Danielsen M; Medina Bornachera D; Alvarez A; Eimon A; Pendón G; Mayer M; Marin J; Catoggio C; Pisoni CN
Lupus; 2018 Jan; 27(1):33-39. PubMed ID: 28385125
[TBL] [Abstract][Full Text] [Related]
11. [Are there associations of health status, disease activity and damage in SLE patients?---Results of a study of a cohort of a Swiss specialized outpatient clinic].
Marx C; Mörgeli HP; Büchi S; Stoll T
Praxis (Bern 1994); 2007 May; 96(22):895-9. PubMed ID: 17601244
[TBL] [Abstract][Full Text] [Related]
12. Disease course in systemic lupus erythematosus: changes in health status, disease activity, and organ damage after 2 years.
Gilboe IM; Kvien TK; Husby G
J Rheumatol; 2001 Feb; 28(2):266-74. PubMed ID: 11246660
[TBL] [Abstract][Full Text] [Related]
13. The effect of menopause on disease activity in systemic lupus erythematosus.
Urowitz MB; Ibañez D; Jerome D; Gladman DD
J Rheumatol; 2006 Nov; 33(11):2192-8. PubMed ID: 16981295
[TBL] [Abstract][Full Text] [Related]
14. Risk of damage and mortality in SLE patients fulfilling the ACR or only the SLICC classification criteria. A 10-year, inception cohort study.
Inês L; Rodrigues M; Jesus D; Fonseca FP; Silva JAP
Lupus; 2018 Apr; 27(4):556-563. PubMed ID: 28933234
[TBL] [Abstract][Full Text] [Related]
15. Damage accumulation in systemic lupus erythematosus and its relation to disease activity and mortality.
Becker-Merok A; Nossent HC
J Rheumatol; 2006 Aug; 33(8):1570-7. PubMed ID: 16845708
[TBL] [Abstract][Full Text] [Related]
16. Prediction of chronic damage in systemic lupus erythematosus by using machine-learning models.
Ceccarelli F; Sciandrone M; Perricone C; Galvan G; Morelli F; Vicente LN; Leccese I; Massaro L; Cipriano E; Spinelli FR; Alessandri C; Valesini G; Conti F
PLoS One; 2017; 12(3):e0174200. PubMed ID: 28329014
[TBL] [Abstract][Full Text] [Related]
17. Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosus.
Stoll T; Gordon C; Seifert B; Richardson K; Malik J; Bacon PA; Isenberg DA
J Rheumatol; 1997 Aug; 24(8):1608-14. PubMed ID: 9263159
[TBL] [Abstract][Full Text] [Related]
18. Can health utility measures be used in lupus research? A comparative validation and reliability study of 4 utility indices.
Moore AD; Clarke AE; Danoff DS; Joseph L; Bélisle P; Neville C; Fortin PR
J Rheumatol; 1999 Jun; 26(6):1285-90. PubMed ID: 10381044
[TBL] [Abstract][Full Text] [Related]
19. Outcome measures to be used in clinical trials in systemic lupus erythematosus.
Strand V; Gladman D; Isenberg D; Petri M; Smolen J; Tugwell P
J Rheumatol; 1999 Feb; 26(2):490-7. PubMed ID: 9972993
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with fatigue in patients with systemic lupus erythematosus.
Bruce IN; Mak VC; Hallett DC; Gladman DD; Urowitz MB
Ann Rheum Dis; 1999 Jun; 58(6):379-81. PubMed ID: 10340963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
